Even with its demonstrated toxicity, Dr. Fauci used CRI parallel-track process to bypass the usual controls, to win approval for use of ddI in pregnant mothers who test positive for HIV. A 2019 study [Hleyhel et al., Environ Mol Mutagen (2019)127] found that ddI accounted for 16 percent of prescriptions for infected mothers and 30 percent of the cancers in their children. In
